The development of imatinib as a therapeutic agent for chronic myeloid leukemia (Q35993288): Difference between revisions

From Wikidata
Jump to navigation Jump to search
Renamerr (talk | contribs)
Changed Ukrainian description: наукова стаття, опублікована в грудні 2004, #quickstatements
Egon Willighagen (talk | contribs)
 
(17 intermediate revisions by 11 users not shown)
label / enlabel / en
The development of imatinib as a therapeutic agent for chronic myeloid leukemia.
The development of imatinib as a therapeutic agent for chronic myeloid leukemia
label / astlabel / ast
 
The development of imatinib as a therapeutic agent for chronic myeloid leukemia
label / nllabel / nl
 
The development of imatinib as a therapeutic agent for chronic myeloid leukemia
description / ptdescription / pt
artigo científico
artigo científico (publicado na 2004)
description / pt-brdescription / pt-br
artigo científico
artigo científico (publicado na 2004)
description / astdescription / ast
artículu científicu
artículu científicu espublizáu en 2004
description / dadescription / da
videnskabelig artikel
videnskabelig artikel (udgivet 2004)
description / frdescription / fr
article scientifique
article scientifique (publié 2004)
description / fadescription / fa
 
مقالهٔ علمی
description / urdescription / ur
 
سائنسی مضمون
Property / titleProperty / title
The development of imatinib as a therapeutic agent for chronic myeloid leukemia. (English)
The development of imatinib as a therapeutic agent for chronic myeloid leukemia (English)
Property / authorProperty / author
Property / instance of
 
Property / instance of: review article / rank
 
Normal rank
Property / instance of: review article / reference
 
Property / main subject
 
Property / main subject: leukemia / rank
 
Normal rank
Property / main subject: leukemia / reference
 
Property / main subject
 
Property / main subject: imatinib / rank
 
Normal rank
Property / main subject: imatinib / reference
 
Property / language of work or name
 
Property / language of work or name: English / rank
 
Normal rank
Property / Fatcat ID
 
Property / Fatcat ID: release_u7mrqcbq7fcnpo4jc4elt4rf7i / rank
 
Normal rank
Property / Fatcat ID: release_u7mrqcbq7fcnpo4jc4elt4rf7i / reference
 
Property / cites work
 
Property / cites work: RETRACTED: Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class / rank
 
Normal rank
Property / cites work: RETRACTED: Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class / reference
 
stated in: COCI
retrieved: 30 December 2023
Timestamp+2023-12-30T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

reference URL: https://opencitations.net/index/api/v1/citations/10.1073/PNAS.92.7.2558

Latest revision as of 09:49, 30 December 2023

scientific article
Language Label Description Also known as
English
The development of imatinib as a therapeutic agent for chronic myeloid leukemia
scientific article

    Statements

    The development of imatinib as a therapeutic agent for chronic myeloid leukemia (English)
    0 references

    Identifiers